{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:25:04Z","timestamp":1777433104949,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["ES007250-06"],"award-info":[{"award-number":["ES007250-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA196658"],"award-info":[{"award-number":["CA196658"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"U.S. Department of Health & Human Services | NIH | National Center for Research Resources","doi-asserted-by":"publisher","award":["RR027015-01"],"award-info":[{"award-number":["RR027015-01"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41375-018-0188-8","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T15:00:59Z","timestamp":1530284459000},"page":"75-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Time resolved quantitative phospho-tyrosine analysis reveals Bruton\u2019s Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-9216","authenticated-orcid":false,"given":"Pankaj","family":"Dwivedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Muench","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Azam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8162-6758","authenticated-orcid":false,"given":"H. Leighton","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth D.","family":"Greis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"key":"188_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.hoc.2012.10.002","volume":"27","author":"IP Touw","year":"2013","unstructured":"Touw IP, Palande K, Beekman R. Granulocyte colony-stimulating factor receptor signaling: implications for G-CSF responses and leukemic progression in severe congenital neutropenia. Hematol Oncol Clin North Am. 2013;27:61\u201373.","journal-title":"Hematol Oncol Clin North Am"},{"key":"188_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exphem.2016.10.008","volume":"46","author":"P Dwivedi","year":"2017","unstructured":"Dwivedi P, Greis KD. Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies. Exp Hematol. 2017;46:9\u201320.","journal-title":"Exp Hematol"},{"key":"188_CR3","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1182\/blood-2010-01-234120","volume":"115","author":"R Beekman","year":"2010","unstructured":"Beekman R, Touw IP. G-CSF and its receptor in myeloid malignancy. Blood. 2010;115:5131\u20136.","journal-title":"Blood"},{"key":"188_CR4","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1182\/blood-2005-11-4370","volume":"107","author":"PS Rosenberg","year":"2006","unstructured":"Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Chem B, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood. 2006;107:4628\u201335.","journal-title":"Blood"},{"key":"188_CR5","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1182\/blood-2013-05-500959","volume":"122","author":"J Gotlib","year":"2013","unstructured":"Gotlib J, Maxson JE, George TI, Tyner JW. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood. 2013;122:1707\u201311.","journal-title":"Blood"},{"key":"188_CR6","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3324\/haematol.2013.090571","volume":"98","author":"IP Touw","year":"2013","unstructured":"Touw IP, Beekman R. Severe congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R. Haematologica. 2013;98:1490\u20132.","journal-title":"Haematologica"},{"key":"188_CR7","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1182\/blood-2009-12-259630","volume":"116","author":"H Zhang","year":"2010","unstructured":"Zhang H, Nguyen-Jackson H, Panopoulos AD, Li HS, Murray PJ, Watowich SS. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood. 2010;116:2462\u201371.","journal-title":"Blood"},{"key":"188_CR8","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1182\/blood-2012-01-406116","volume":"119","author":"R Beekman","year":"2012","unstructured":"Beekman R, Valkhof MG, Sanders MA, van Strien PM, Haanstra JR, Broeders L, et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood. 2012;119:5071\u20137.","journal-title":"Blood"},{"key":"188_CR9","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/leu.2013.164","volume":"27","author":"HM Mehta","year":"2013","unstructured":"Mehta HM, Glaubach T, Long A, Lu H, Przychodzen B, Makishima H, et al. Granulocyte colony stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling. Leukemia. 2013;27:2407\u201310.","journal-title":"Leukemia"},{"key":"188_CR10","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","volume":"368","author":"JE Maxson","year":"2013","unstructured":"Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013;368:1781\u201390.","journal-title":"N Engl J Med"},{"key":"188_CR11","first-page":"946","volume":"118","author":"F Liu","year":"2008","unstructured":"Liu F, Kunter G, Krem MM, Eades WC, Cain JA, Tomasson MH, et al. Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5. J Clin Invest. 2008;118:946\u201355.","journal-title":"J Clin Invest"},{"key":"188_CR12","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/leu.2013.122","volume":"27","author":"A Pardanani","year":"2013","unstructured":"Pardanani A, Lasho TL, Laborde RR, Elliott M, Hanson CA, Knudson RA, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia. 2013;27:1870\u20133.","journal-title":"Leukemia"},{"key":"188_CR13","first-page":"67","volume":"3","author":"KH Dao","year":"2014","unstructured":"Dao KH, Solti MB, Maxson JE. Significant clinical response to JAK1\/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia. Leuk Res Rep. 2014;3:67\u20139.","journal-title":"Leuk Res Rep"},{"key":"188_CR14","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/leu.2016.376","volume":"31","author":"S Rohrabaugh","year":"2017","unstructured":"Rohrabaugh S, Kesarwani M, Kincaid Z, Huber E, Leddonne J, Siddiqui Z, et al. Enhanced MAPK signaling is essential for CSF3R-induced leukemia. Leukemia. 2017;31:1770\u20138.","journal-title":"Leukemia"},{"key":"188_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ceb.2009.01.028","volume":"21","author":"Hunter Tony","year":"2009","unstructured":"Tony Hunter. Tyrosine phosphorylation: thirty years and counting. Curr Opin Cell Biol. 2009;21:140\u20136.","journal-title":"Curr Opin Cell Biol"},{"key":"188_CR16","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1038\/nprot.2006.427","volume":"1","author":"SE Ong","year":"2006","unstructured":"Ong SE, Mann M. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc. 2006;1:2650\u201360.","journal-title":"Nat Protoc"},{"key":"188_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nbt1046","volume":"23","author":"J Rush","year":"2005","unstructured":"Rush J, Moritz A, Lee KA, Guo A, Goss VL, Spek EJ, et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol. 2005;23:94\u2013101.","journal-title":"Nat Biotechnol"},{"key":"188_CR18","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein\u2013protein interaction networks, integrated over the tree of life. Nucleic Acid Res. 2015; 43:D447\u201352","DOI":"10.1093\/nar\/gku1003"},{"key":"188_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/bioinformatics\/btp026","volume":"25","author":"A Lachmann","year":"2009","unstructured":"Lachmann A, Ma\u2019ayan A. KEA: kinase enrichment analysis. Bioinformatics. 2009;25:684\u20136.","journal-title":"Bioinformatics"},{"key":"188_CR20","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1074\/jbc.M113.508440","volume":"289","author":"JE Maxson","year":"2014","unstructured":"Maxson JE, Luty SB, MacManiman JD, Abel ML, Druker BJ, Tyner JW. Ligand independence of the T618I mutation in the granulocyte colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization. J Biol Chem. 2014;289:5820\u20137.","journal-title":"J Biol Chem"},{"key":"188_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1084\/jem.189.4.683","volume":"189","author":"MH Hermans","year":"1999","unstructured":"Hermans MH, Antonissen C, Ward AC, Mayen AE, Ploemacher RE, Touw IP. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia\/acute myeloid leukemiaderived mutation in the G-CSF receptor gene. J Exp Med. 1999;189:683\u201392.","journal-title":"J Exp Med"},{"key":"188_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1182\/blood-2003-07-2250","volume":"104","author":"LH Aarts","year":"2004","unstructured":"Aarts LH, Roovers O, Ward AC, Touw IP. Receptor activation and 2 distinct COOHterminal motifs control G-CSF receptor distribution and internalization kinetics. Blood. 2004;104:571\u20139.","journal-title":"Blood"},{"key":"188_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/nm.3884","volume":"21","author":"WH Wilson","year":"2015","unstructured":"Wilson WH, Young RM, Schmitz RS, Yang Y, Pittaluga S, Wright G, et al. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med. 2015;21:922\u20136.","journal-title":"Nat Med"},{"key":"188_CR24","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood-2013-06-511154","volume":"123","author":"SA Rushworth","year":"2014","unstructured":"Rushworth SA, Murray MY, Zaitseva L, Bowles KM, MacEwan DJ. Identification of Bruton\u2019s tyrosine kinase as a therapeutic target in acute myeloid leukemia. Blood. 2014;123:1229\u201338.","journal-title":"Blood"},{"key":"188_CR25","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1182\/blood-2014-06-585216","volume":"125","author":"T Oellerich","year":"2015","unstructured":"Oellerich T, Mohr S, Corso J, Beck J, Dobele C, Braun H, et al. FLT3-ITD and TLR9 use Bruton Tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation. Blood. 2015;125:1936\u201347.","journal-title":"Blood"},{"key":"188_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nature11249","volume":"487","author":"TR Wilson","year":"2012","unstructured":"Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature. 2012;487:505\u20139.","journal-title":"Nature"},{"key":"188_CR27","doi-asserted-by":"publisher","first-page":"23899","DOI":"10.1074\/jbc.M110.115295","volume":"285","author":"M Stuible","year":"2010","unstructured":"Stuible M, Abella JV, Feldhammer M, Nossov M, Sangwan V, Blagoev B, et al. Ptpb1b targets the endosomal sorting machinery: dephosphorylation of regulatory sites in the endosomal sorting complex required for transport component STAM2. J Biol Chem. 2010;285:23899\u2013907.","journal-title":"J Biol Chem"},{"key":"188_CR28","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1038\/sj.onc.1205670","volume":"21","author":"L Wang","year":"2002","unstructured":"Wang L, Rudert WA, Loutaev I, Roginskaya V, Corey SJ. Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation. Oncogene. 2002;21:5346\u201355.","journal-title":"Oncogene"},{"key":"188_CR29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/ncb2257","volume":"13","author":"C Joffre","year":"2011","unstructured":"Joffre C, Barrow R, Menard L, Calleja V, Hart IP, Kermogrant S. A direct role for Met endocytosis in tumorigenesis. Nat Cell Biol. 2011;13:827\u201337.","journal-title":"Nat Cell Biol"},{"key":"188_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.1073096","volume":"297","author":"IB Weinstein","year":"2002","unstructured":"Weinstein IB. Addiction to oncogenes-the Achilles heal of Cancer. Science. 2002;297:63\u20134.","journal-title":"Science"},{"key":"188_CR31","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nm.4310","volume":"23","author":"M Kesharwani","year":"2017","unstructured":"Kesharwani M, Kincaid Z, Gomaa A, Huber E, Rohrabaugh S, Siddiqui Z, et al. Trageting c-Fos and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia. Nat Med. 2017;23:472\u201382.","journal-title":"Nat Med"},{"key":"188_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ccr.2013.01.011","volume":"23","author":"C Khandanpour","year":"2013","unstructured":"Khandanpour C, Phelan JD, Vassen L, Schutte J, Chen R, Horman SR, et al. Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia. Cancer Cell. 2013;23:200\u201314.","journal-title":"Cancer Cell"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0188-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0188-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0188-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:35:14Z","timestamp":1684618514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-018-0188-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["188"],"URL":"https:\/\/doi.org\/10.1038\/s41375-018-0188-8","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,5]]},"assertion":[{"value":"19 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}